ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004